感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2015 INHSU建议：注射吸毒者HCV感染的管理

2015-10-01 国际药物滥用者肝炎网络 Int J Drug Policy. 2015 Oct;26(10):1028-38.

HCV

2015年10月，国际药物滥用者肝炎网络(INHSU)发布了注射吸毒者HCV感染的管理建议，该建议针对注射吸毒人群HCV感染的治疗和护理提供了一个框架。

中文标题：

2015 INHSU建议：注射吸毒者HCV感染的管理

英文标题：

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

发布机构：

国际药物滥用者肝炎网络

发布日期：

2015-10-01

简要介绍：

2015年10月，国际药物滥用者肝炎网络(INHSU)发布了注射吸毒者HCV感染的管理建议，该建议针对注射吸毒人群HCV感染的治疗和护理提供了一个框架。


拓展指南：与HCV感染相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2015 INHSU建议：注射吸毒者HCV感染的管理)] GetToolGuiderByIdResponse(projectId=1, id=e83321c00125a257, title=2015 INHSU建议：注射吸毒者HCV感染的管理, enTitle=Recommendations for the management of hepatitis C virus infection among people who inject drugs., guiderFrom=Int J Drug Policy. 2015 Oct;26(10):1028-38., authorId=null, author=, summary=2015年10月，国际药物滥用者肝炎网络(INHSU)发布了注射吸毒者HCV感染的管理建议，该建议针对注射吸毒人群HCV感染的治疗和护理提供了一个框架。, cover=, journalId=null, articlesId=null, associationId=1233, associationName=国际药物滥用者肝炎网络, associationIntro=, copyright=0, guiderPublishedTime=Thu Oct 01 00:00:00 CST 2015, originalUrl=, linkOutUrl=, content=2015年10月，国际药物滥用者肝炎网络(INHSU)发布了注射吸毒者HCV感染的管理建议，该建议针对注射吸毒人群HCV感染的治疗和护理提供了一个框架。 <div><br> </div>拓展指南：<strong>与<font color="red">HCV感染</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=a452b1c001208583" title="2015年ASBMT建议：造血细胞移植捐赠者和接受者之间HCV感染" target="_blank">2015年ASBMT建议：造血细胞移植捐赠者和接受者之间HCV感染</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d830d1c00120830c" title="2016年WHO指南：HCV感染患者的筛查、护理和治疗（更新版）" target="_blank">2016年WHO指南：HCV感染患者的筛查、护理和治疗（更新版）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=da5991c001208191" title="《日本肝病学会指南：基因1型及2型HCV感染管理（2016年更新）》推荐意见" target="_blank">《日本肝病学会指南：基因1型及2型HCV感染管理（2016年更新）》推荐意见</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=8fe1f1c0012080bf" title="2016年澳大利亚HCV感染管理建议" target="_blank">2016年澳大利亚HCV感染管理建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4f4951c00120e83a" title="2016年美国预防医学会关于HCV感染的立场声明" target="_blank">2016年美国预防医学会关于HCV感染的立场声明</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=HCV%E6%84%9F%E6%9F%93" target="_blank">有关HCV感染更多指南</a></ul>, tagList=[TagDto(tagId=590, tagName=HCV)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3233, appHits=18, showAppHits=0, pcHits=2228, showPcHits=1315, likes=114, shares=0, comments=3, approvalStatus=1, publishedTime=Mon Aug 15 18:00:46 CST 2016, publishedTimeString=2015-10-01, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Mon Aug 15 18:00:46 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:06:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2015 INHSU建议：注射吸毒者HCV感染的管理)])
2015 INHSU建议：注射吸毒者HCV感染的管理
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=101687, encodeId=b8ac10168e8b, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:52:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99864, encodeId=95b8998649f, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 17:35:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99865, encodeId=e77c99865c2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 17:35:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-20 doctorJiangchao

    继续关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=101687, encodeId=b8ac10168e8b, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:52:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99864, encodeId=95b8998649f, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 17:35:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99865, encodeId=e77c99865c2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 17:35:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=101687, encodeId=b8ac10168e8b, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 17:52:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99864, encodeId=95b8998649f, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 17:35:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99865, encodeId=e77c99865c2, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 17:35:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续学习

    0

相关指南

2016年WHO指南：HCV感染患者的筛查、护理和治疗（更新版）

世界卫生组织(WHO,The World Health Organization) · 2016-04-13

《日本肝病学会指南：基因1型及2型HCV感染管理（2016年更新）》推荐意见

日本肝脏学会(JSH,The Japan Society of Hepatology) · 2016-06-08

2016年澳大利亚HCV感染管理建议

澳大利亚胃肠病学会(GESA,Gastroenterological Seciety of Australia) · 2016-06-08

2016年美国预防医学会关于HCV感染的立场声明

美国预防医学学会(ACPM,American College of Preventive Medicine) · 2016-05-01

2013 EASL 丙型肝炎病毒（HCV）感染诊治临床实践指南(修订版)

欧洲肝脏研究学会(EASL,European Association for the Study of the Liver) · 2013-12-18